Results 91 to 100 of about 54,591 (139)

Effects of breast size on breast reconstruction in BRCA mutation carriers and genetic high-risk patients after bilateral mastectomy. [PDF]

Breast Cancer
Lam MC, Grufman V, Fertsch S, Recker F, Speck NE, Farhadi J.   +5 more
europepmc   +1 more source

Tislelizumab plus AG regimen for long-term CR in 2 patients with metastatic BRCA-mutation pancreatic cancer: A case report. [PDF]

Medicine (Baltimore)
Gao F, Xu X, Chen C, Lv L.
europepmc   +1 more source

Patenting the Fingerprint of God: How Gene Patents Violate the Products of Nature Doctrine [PDF]

, 2015
Todd, Timothy M.
core   +1 more source

Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. [PDF]

Biomedicines
Szentmartoni G, Mühl D, Csanda R, Szasz AM, Herold Z, Dank M.   +5 more
europepmc   +1 more source

Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis. [PDF]

Cancer
Liu YL, Mathews CA, Simpkins F, Cadoo KA, Provencher D, McCormick CC, ElNaggar AC, Altman AD, Gilbert L, Black D, Kabil N, Taylor RN, Barnicle A, Munley JY, Aghajanian C.   +14 more
europepmc   +1 more source

Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers. [PDF]

NPJ Breast Cancer
Myers SP, Sevilimedu V, Barrio AV, Tadros AB, Mamtani A, Robson ME, Morrow M, Lee MK.   +7 more
europepmc   +1 more source

Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A systematic review and meta-analysis protocol. [PDF]

PLoS One
Patra A, Ali SS, Devi NM, Qadeer AS, Kamalakannan S, Nag S, Kulkarni SS, Rajappa S, Hariharan N, Pant HB, Agiwal V, A Y N.   +11 more
europepmc   +1 more source

Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging in Magnetic Resonance in the Assessment of Peritoneal Recurrence of Ovarian Cancer in Patients with or Without BRCA Mutation. [PDF]

Cancers (Basel)
Jankowska-Lombarska M, Grabowska-Derlatka L, Kraj L, Derlatka P.   +3 more
europepmc   +1 more source

The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation. [PDF]

J Gynecol Oncol
Lee YJ, Kim W, Hong S, Lee YJ, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ.   +8 more
europepmc   +1 more source

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey. [PDF]

J Gynecol Oncol
Palaia I, Caruso G, Di Donato V, Turetta C, Savarese A, Perniola G, Gallo R, Giannini A, Salutari V, Bogani G, Tomao F, Giannarelli D, Gentile G, Musella A, Muzii L, Pignata S, MITO group.   +16 more
europepmc   +1 more source